1. Home
  2. RGEN vs GMED Comparison

RGEN vs GMED Comparison

Compare RGEN & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • GMED
  • Stock Information
  • Founded
  • RGEN 1981
  • GMED 2003
  • Country
  • RGEN United States
  • GMED United States
  • Employees
  • RGEN N/A
  • GMED N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • GMED Medical/Dental Instruments
  • Sector
  • RGEN Health Care
  • GMED Health Care
  • Exchange
  • RGEN Nasdaq
  • GMED Nasdaq
  • Market Cap
  • RGEN 8.2B
  • GMED 9.7B
  • IPO Year
  • RGEN N/A
  • GMED 2012
  • Fundamental
  • Price
  • RGEN $143.40
  • GMED $69.26
  • Analyst Decision
  • RGEN Buy
  • GMED Buy
  • Analyst Count
  • RGEN 10
  • GMED 12
  • Target Price
  • RGEN $188.38
  • GMED $77.36
  • AVG Volume (30 Days)
  • RGEN 920.4K
  • GMED 628.6K
  • Earning Date
  • RGEN 10-29-2024
  • GMED 11-05-2024
  • Dividend Yield
  • RGEN N/A
  • GMED N/A
  • EPS Growth
  • RGEN N/A
  • GMED N/A
  • EPS
  • RGEN N/A
  • GMED 0.30
  • Revenue
  • RGEN $602,354,000.00
  • GMED $2,236,530,000.00
  • Revenue This Year
  • RGEN $0.08
  • GMED $61.37
  • Revenue Next Year
  • RGEN $12.97
  • GMED $7.07
  • P/E Ratio
  • RGEN N/A
  • GMED $227.06
  • Revenue Growth
  • RGEN N/A
  • GMED 103.89
  • 52 Week Low
  • RGEN $110.45
  • GMED $43.39
  • 52 Week High
  • RGEN $211.13
  • GMED $74.21
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 44.56
  • GMED 43.89
  • Support Level
  • RGEN $139.41
  • GMED $69.25
  • Resistance Level
  • RGEN $150.72
  • GMED $71.29
  • Average True Range (ATR)
  • RGEN 5.27
  • GMED 1.38
  • MACD
  • RGEN -0.93
  • GMED -0.26
  • Stochastic Oscillator
  • RGEN 28.36
  • GMED 29.37

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

Share on Social Networks: